Clinical Overview: REVLIMID
You’re invited to a live speaker program on pivotal data for newly diagnosed MM patients:
Clinical Overview: REVLIMID for Transplant and Non-Transplant Patients with Newly Diagnosed MM
Robert Vescio, M.D.
You may also register by contacting Program Registration at firstname.lastname@example.org or calling (866) 991-3694. Please provide your name, degree, office address, phone number, and e-mail address.